Catalyst Wire Dossier Catalyst Wire Dossier
CLINICAL_TRIALS trial_result · 2025-01-29

Clinical Trial Update: Targeting Aging and Promoting Longevity with Exogenous Nucleotides (TALENTs) [NA]

View source ↗

Summary

A study sponsored by Peking University investigating aging and longevity using exogenous nucleotides has completed.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

Drugs mentioned

  • Exogenous nucleotides (exogenous nucleotides)

Snippet

Sponsor: Peking University | Conditions: Aging | NA | Status: COMPLETED